Emerging drugs for partial-onset epilepsy: a review of brivaracetam
Lan Gao,1 Shuchuen Li2 1Deakin Population Health SRC, Faculty of Health, Deakin University, Burwood, Victoria, 2School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, NSW, Australia Abstract: There are more than 12 new antiepileptic drugs approved in the last 2 decades...
Main Authors: | Gao L, Li SC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/emerging-drugs-for-partial-onset-epilepsy-a-review-of-brivaracetam-peer-reviewed-article-TCRM |
Similar Items
Similar Items
-
New developments in the management of partial-onset epilepsy: role of brivaracetam
by: Coppola G, et al.
Published: (2017-03-01) -
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
by: Tambucci R, et al.
Published: (2016-05-01) -
Surgical management of cavernous malformations coursing with drug resistant epilepsy
by: Mario Arturo Alonso-Vanegas, et al.
Published: (2012-01-01) -
Efficacy and tolerability of brivaracetam in the treatment of epilepsy: literature review and own experience
by: O. A. Pylaeva, et al.
Published: (2018-11-01) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
by: Feyissa AM
Published: (2019-09-01)